Procter & Gamble vs Honeywell
Globaler Riese für Basiskonsumgüter mit vielfältigen Haushaltsmarken vs Diversifizierter Industrie- und Technologiekonzern mit Geschäftsbereichen für Luft- und Raumfahrt sowie Gebäudetechnik. Welche Aktie passt im September 2026 besser zu Ihrem Portfolio? Die Antwort in einfacher Sprache finden Sie unten.
Procter & Gamble prices its consumer staples brands at premiums that millions of households accept without thinking while Honeywell sells automation, safety, and aerospace solutions to industrial and commercial customers who buy on performance, not habit. Both companies are large-cap industrials-adjacent businesses with decades of dividend growth and pricing power, but their end-market dynamics differ sharply. The Procter & Gamble vs Honeywell comparison reveals how brand loyalty economics and industrial technology value propositions translate into distinctly different earnings growth trajectories.
Procter & Gamble prices its consumer staples brands at premiums that millions of households accept without thinking while Honeywell sells automation, safety, and aerospace solutions to industrial and ...
Was den Kurs bewegt
P&G is in focus as investors look for clearer signs of demand momentum after a mixed fiscal 2026 finish.
- P&G is drawing attention into its September 10 Barclays conference appearance, where management is expected to update investors on category demand and cost pressures after a mixed fiscal 2026 finish.
- The company’s latest fiscal 2026 results showed sales growth of 3%, but organic growth was only 1%, reinforcing the view that pricing and foreign exchange helped more than underlying volume momentum.
- Recent commentary has focused on whether P&G can reaccelerate in the year ahead as analysts watch for signs of steadier consumer demand, especially in the U.S. and China.
HON slips as analysts weigh settlement headlines against a reshaped industrial story
- Honeywell’s recent move appears tied to a mix of analyst caution and a fresh cybersecurity settlement tied to its aerospace business, which is feeding concerns about execution and reputational drag.
- The company’s ongoing breakup into separate businesses is keeping the market focused on what the remaining HON ticker represents, and investors are still reassessing whether the slimmer industrial automation story is enough to support valuation.
- With no major stock-specific catalyst beyond the past week, shares are also trading against a broader backdrop of mixed analyst sentiment and softer near-term expectations for the industrials group.
P&G is in focus as investors look for clearer signs of demand momentum after a mixed fiscal 2026 finish.
- P&G is drawing attention into its September 10 Barclays conference appearance, where management is expected to update investors on category demand and cost pressures after a mixed fiscal 2026 finish.
- The company’s latest fiscal 2026 results showed sales growth of 3%, but organic growth was only 1%, reinforcing the view that pricing and foreign exchange helped more than underlying volume momentum.
- Recent commentary has focused on whether P&G can reaccelerate in the year ahead as analysts watch for signs of steadier consumer demand, especially in the U.S. and China.
HON slips as analysts weigh settlement headlines against a reshaped industrial story
- Honeywell’s recent move appears tied to a mix of analyst caution and a fresh cybersecurity settlement tied to its aerospace business, which is feeding concerns about execution and reputational drag.
- The company’s ongoing breakup into separate businesses is keeping the market focused on what the remaining HON ticker represents, and investors are still reassessing whether the slimmer industrial automation story is enough to support valuation.
- With no major stock-specific catalyst beyond the past week, shares are also trading against a broader backdrop of mixed analyst sentiment and softer near-term expectations for the industrials group.
Anlageanalyse
Vorteile
- Procter & Gamble has a strong global presence with a diversified portfolio including beauty, grooming, healthcare, and household care segments.
- Analysts maintain a consensus 'Buy' rating with an average price target suggesting a potential 19-20% upside over the next year.
- The company has consistent dividend payments, making it attractive for income-focused investors seeking steady returns.
Zu beachten
- Recent insider selling has raised concerns about future performance and may indicate cautious sentiment from key executives.
- The stock currently trades at a relatively high price-to-earnings ratio compared to its earnings potential, suggesting possible overvaluation.
- Procter & Gamble’s stock price has shown volatility with fluctuations between approximately $147 and $180 over the last year, which might deter risk-averse investors.
Honeywell
HON
Vorteile
- Honeywell reported robust Q2 2025 earnings that exceeded estimates and raised its adjusted EPS guidance for the year.
- The company’s aerospace division is a key growth driver, considered undervalued by analysts and poised for higher valuation multiples.
- Recent strategic moves, including acquisitions and a planned three-way corporate split, aim to unlock value and enhance shareholder returns.
Zu beachten
- Honeywell’s stock trades at a higher price-to-book ratio relative to sector averages, implying a premium valuation that may limit upside.
- The company operates in cyclical industrial sectors, exposing it to macroeconomic fluctuations that could affect performance.
- Execution risks remain around the announced corporate restructuring and the integration of recent acquisitions, which could impact near-term results.
Procter & Gamble (PG) – Nächster Termin für Quartalszahlen
The next earnings date for PG is expected to be October 22, 2026, based on its historical reporting pattern. This release should cover fiscal Q1 2027. If the company confirms a date, it may shift by a day or two, but late October is the current expectation.
Honeywell (HON) – Nächster Termin für Quartalszahlen
Honeywell’s next earnings date for HON is expected on October 22, 2026, based on its typical reporting pattern and current estimates. The report should cover Q3 2026. Management has not yet formally confirmed the date, so it could still shift slightly.
Procter & Gamble (PG) – Nächster Termin für Quartalszahlen
The next earnings date for PG is expected to be October 22, 2026, based on its historical reporting pattern. This release should cover fiscal Q1 2027. If the company confirms a date, it may shift by a day or two, but late October is the current expectation.
Honeywell (HON) – Nächster Termin für Quartalszahlen
Honeywell’s next earnings date for HON is expected on October 22, 2026, based on its typical reporting pattern and current estimates. The report should cover Q3 2026. Management has not yet formally confirmed the date, so it could still shift slightly.
PG oder HON in Nemo kaufen
Ohne Provision
Handeln Sie Aktien, ETFs und mehr ohne Provision. Behalten Sie mehr von Ihrer Rendite.
Vertrauenswürdig & reguliert
Seit 2015 Teil der Exinity Group, mit über einer Million Kunden weltweit.
6 % Zinsen auf Guthaben
Erhalten Sie 6 % Zinsen p.a. auf nicht investiertes Guthaben, mit täglicher Zinsgutschrift.
